Internist McClellan Placates Kennedy Industry Concerns; Is That Enough?
This article was originally published in The Tan Sheet
Executive Summary
White House economic advisor Mark McClellan's viability as the next FDA commissioner may hinge on Senate HELP Committee Chairman Edward Kennedy's (D-Mass.) willingness to look beyond the internist's strong ties to the Bush Administration
You may also be interested in...
Senate Health Committee Eyes October Hearing For McClellan
The Senate Health Committee appears to be fast-tracking the confirmation process for FDA commissioner nominee Mark McClellan, MD/PhD
Senate Health Committee Eyes October Hearing For McClellan
The Senate Health Committee appears to be fast-tracking the confirmation process for FDA commissioner nominee Mark McClellan, MD/PhD
Senate Health Committee Eyes October Hearing For McClellan
The Senate Health Committee appears to be fast-tracking the confirmation process for FDA commissioner nominee Mark McClellan, MD/PhD